Recent developments
Portfolio realignment
The dsm-firmenich Q3 2025 update reports 2% organic sales growth and higher adjusted EBITDA, with full-year EBITDA guided to about €2.3 billion. Foreign exchange reduces results by €90 million and vitamin contributions in ANH by €50 million. The company plans to complete its ANH business divestment by Q4 2025 and has executed 85% of its €1 billion buyback.
Amino acid logistics
Evonik used a planned Antwerp methionine shutdown to install new filling equipment and expand storage, enhancing packaging flexibility. The Antwerp logistics for MetAMINO now support 1,000 kg big bags, 25 kg bags with a 20% CO2 reduction versus the previous version, and bulk shipments. Capacity exceeds 700,000 t across Antwerp, Mobile, and Singapore amid rising demand for larger packaging units.
Vitamin formulation advances
BASF introduced Lutavit® A/D3 1000/200 NXT, combining vitamins A and D3 in a single microencapsulated product. It is produced at Ludwigshafen and shows stability in premixes and pellets. The formulation provides an 18-month shelf life under standard storage and maintains a 5:1 A:D3 ratio across species, with established vitamin A bioavailability.